Drug that harmed 20,000 babies still being prescribed to pregnant women

South Africa News News

Drug that harmed 20,000 babies still being prescribed to pregnant women
South Africa Latest News,South Africa Headlines
  • 📰 The Independent
  • ⏱ Reading Time:
  • 1 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 4%
  • Publisher: 59%

Former health secretary Jeremy Hunt says epilepsy drug sodium valproate ‘a major risk to patient safety’

According to the latest figures, 222 pregnant women were exposed to sodium valproate in the period 2020-2021 the Medicines and Healthcare products Regulatory Agency said.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

The Independent /  🏆 80. in UK

South Africa Latest News, South Africa Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Opinion: Bend It Like Beckham is just as iconic now as it was 20 years agoOpinion: Bend It Like Beckham is just as iconic now as it was 20 years agoI became fixated on the image of a girl who looked like me – in a Manchester United football shirt, no less
Read more »

Genetic screening can improve drug prescribingGenetic screening can improve drug prescribingCommon mutations can affect how well a drug works, or even whether it is toxic to some patients
Read more »

Mums-to-be still being given unsafe epilepsy drugMums-to-be still being given unsafe epilepsy drugA pill linked to physical malformations, autism and developmental delay in children is still being prescribed to pregnant women
Read more »

Mums-to-be still being given unsafe epilepsy drugMums-to-be still being given unsafe epilepsy drugA pill linked to physical malformations, autism and developmental delay in children is still being prescribed to pregnant women
Read more »

Medical regulator faces questions over board members’ links to drug firmsMedical regulator faces questions over board members’ links to drug firmsConcerns over potential conflicts of interest lead to calls for regulator’s policy to be strengthened
Read more »



Render Time: 2025-03-31 09:14:11